Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol for inflammatory markers in hypertensive intracranial hemorrhage
ChiCTR1900022612Phase 4Recruiting
- Sponsor
- The First People's Hospital of Longquanyi District, Chengdu
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of metoprolol in intracerebral hemorrhage (ICH) and hypertension (HTN) (2 arms), sponsored by The First People's Hospital of Longquanyi District, Chengdu. Primary endpoints: Procalcitonin (PCT), C-reactive protein (CRP) and 1 more. Started Apr 2019; status: recruiting.
02
Drugs
metoprolol
03
Conditions
intracerebral hemorrhage (ICH)hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR1900022612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022612.